Helius Medical Technologies was supposed to pioneer treatments for damaged nervous systems. Instead, it’s their Nasdaq ticker that flatlined.
Pull up the chart and it doesn’t look like a financial instrument — it looks like a patient monitor in the ICU. A slow, jagged decline punctuated by occasional jolts of artificial life. In late capitalism, companies don’t die — they pivot.
And Helius just pivoted in the most surreal way possible: from medical devices to crypto treasuries.
Helius announced over $500 million in funding with another $750 million stapled in warrants to build a Solana-denominated treasury. Pantera Capital and Summer Capital led the deal, with a roster of institutional investors backing the plan.
On paper, it makes sense. Bitcoin doesn’t yield. Solana does. And in a market obsessed with yield, a medical company is now playing balance-sheet arbitrage with crypto.
This pivot didn’t come from strength — it came from survival.
Helius has conducted reverse stock splits so many times that the cumulative effect is over 1-for-6.5 million. In plain English: if you held millions of shares years ago, you’d have one today.


